Search clinical trials for: Nebulized Budesonide

Total 790 results

AstraZeneca

Completed

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

Asthma | Severe Eosinophilic Asthma

France, Germany, Italy, United Kingdom
Bond Avillion 2 Development LP

Completed

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma (MANDALA)

Asthma

United States, Canada, Germany, Spain, South Africa, United Kingdom, Slovakia, Argentina, Ukraine, Serbia, Czechia
AstraZeneca

Completed

A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy (CHASE 2)

Asthma

United States, South Africa, Hungary, Bulgaria, Czech Republic, Poland
AstraZeneca

Completed

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Chronic Obstructive Pulmonary Disease, COPD

Sweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain
Gilead Sciences

Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

HIV | Hepatitis C Virus

United States, New Zealand, Canada, Puerto Rico
Erasmus Medical Center
Gilead Sciences; Nexstar Pharmaceuticals

Completed

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Aspergillosis

Netherlands
AstraZeneca

Recruiting

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD). (ATHLOS)

Chronic Obstructive Pulmonary Disease

Germany, Spain, United States, China, Korea, Republic of, Argentina, United Kingdom, Canada
Azienda Policlinico Umberto I

Completed

Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis

Eosinophilic Esophagitis

Italy
University Hospital Tuebingen
Dr. Falk Pharma GmbH; Principal Investigator: Univ. Hosp. Tuebingen, Dept....

Completed

Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers

Healthy
Hamad Medical Corporation

Recruiting

Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children

Procedural Pain | Procedural Anxiety

Qatar
University Hospital, Antwerp
AstraZeneca

Completed

Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.

Chronic Obstructive Pulmonary Disease

Belgium
Novartis Pharmaceuticals

Withdrawn

Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics

Asthma

Turkey
Bristol-Myers Squibb
Medarex

Completed

A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide

Malignant Melanoma

United States, Peru, Canada, Israel, Italy, United Kingdom
Assistance Publique - Hôpitaux de Paris
AstraZeneca

Completed

Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT (Alloforb)

Obstructive Airway Disease

France
Eurofarma Laboratorios S.A.

Completed

A Comparative Study Between Foraseq And Formoterol/Budesonide Inhalation Capsules in Patients With Asthma (CAINAS)

ASTHMA

Brazil
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...

Not yet recruiting

Pharmacogenomics IND EXEMPT SNP Clinical Study - Crizotinib and Single Nucleotide Polymorphisms (Drugs-SNPs)

Non-Small Cell Lung Cancer

United States
Beijing Chao Yang Hospital

Recruiting

The Effect of Desflurane on Postopertative Cognitive Dysfunction

Postoperative Delirium | Postoperative Cognitive Dysfunction

China
AstraZeneca

Completed

Symbicort Onset of Action 1

Asthma
Allergy and Asthma Center of El Paso
GlaxoSmithKline

Unknown

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

Asthma

United States
Menoufia University

Not yet recruiting

Vitamin D Nasal Drops in Post COVID-19 Parosmia

Parosmia

Egypt
Second Affiliated Hospital, School of Medicine,...
Tongji Hospital; Shenzhen People's Hospital; China-Japan Friendship Hospital; Central... and other collaborators

Recruiting

The Efficacy of Budesonide/Formoterol in Cough Variant Asthma

Cough Variant Asthma

China
Chiesi Farmaceutici S.p.A.

Completed

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Asthma

United Kingdom
Sunovion Respiratory Development Inc.

Completed

Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). (GOLDEN7)

COPD

United Kingdom
Kangbuk Samsung Hospital

Completed

Hemodynamics for Equi-MAC Anesthesia

Anesthesia

Korea, Republic of
Pfizer

Completed

A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy Volunteers

Healthy

Belgium
Hamad Medical Corporation

Not yet recruiting

Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19 (Ventanyl)

COVID-19 Pneumonia
GlaxoSmithKline

Completed

A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

Asthma

Argentina
AstraZeneca

Completed

Atlantis Symbicort

Asthma
EMS

Withdrawn

Proton Pump Inhibitors Use in Patients With Psoriasis

Psoriasis
Hvidovre University Hospital

Recruiting

Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma

Asthma

Denmark
Orion Corporation, Orion Pharma

Terminated

Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway (BufoSwitch)

Asthma | COPD

Norway
Ranjan Dohil
Meritage Pharma, Inc.

Completed

Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Hamilton Health Sciences Corporation
AstraZeneca

Completed

Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?

Mild Intermittent Asthma

Canada
Brigham and Women's Hospital
AstraZeneca

Terminated

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo (AZCO)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Zhujiang Hospital

Unknown

Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients

Bronchial Asthma

China
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma (UNIK)

Asthma

Brazil
AstraZeneca

Completed

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma

Asthma

Sweden
AstraZeneca

Completed

SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma

Asthma

Belgium, Luxembourg
AstraZeneca

Completed

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

Asthma

France
Institute of Liver and Biliary Sciences, India

Withdrawn

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Advanced Cirrhosis

India
Assistance Publique - Hôpitaux de Paris

Terminated

Protective Role of Inhaled Steroids for Covid-19 Infection (INHASCO)

Covid-19 Infection | Hospitalization in Respiratory Disease Department

France
Istituto per la Ricerca e l'Innovazione Biomedica

Completed

The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma

Asthma

Italy
Shanghai University of Traditional Chinese Medicine

Unknown

Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.

Cough Variant Asthma

China
AstraZeneca

Completed

Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD (CODEX)

Chronic Obstructive Pulmonary Disease

Germany, Switzerland
AstraZeneca

Completed

Prevention of Asthma Relapse After Discharge From Emergency (PARADE)

Asthma

Canada
AstraZeneca

Completed

MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults

Asthma

Denmark, Finland, Norway
AstraZeneca

Completed

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

Asthma

Croatia, Czech Republic, Latvia, Lithuania, Portugal, Slovakia, Greece, Iceland, Slovenia, Chile
AstraZeneca

Completed

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

Stable Asthma
Hospital Universitari Vall d'Hebron Research Institute
Bayer; Sociedad Española de Neumología y Cirugía Torácica; Instituto de Salud...

Completed

Inhaled A1AT in Adult Stable Bronchiectasis

Bronchiectasis Adult
R3 Stem Cell

Not yet recruiting

Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions

Stroke | Autoimmune Diseases | Kidney Diseases | Urologic Diseases | Renal Insufficiency | Arthritis | Renal Failure | Alzheimer Disease | Erectile Dysfunction | Cardiomyopathies | Pulmonary Disease | Neurologic Disorder | Orthopedic Disorder | COPD | Cardiac Event | CHF | Neuropathy;Peripheral

3

Subscribe